Investec discloses 685,425 share sale and 609,558 purchase in Advanced Medical Solutions

Separate Rule 8.5 filings show Investec Bank plc trading Advanced Medical Solutions and Gamma Communications shares on August 4, 2026 while acting in client-serving capacity as broker connected to each offer.

Summary

Investec Bank plc made separate Rule 8.5 public dealing disclosures under the UK Takeover Code for trading on August 4, 2026 in Advanced Medical Solutions Group Plc and Gamma Communications Plc. In the Advanced Medical Solutions filing, Investec, identified as adviser and joint broker to the company, bought 609,558 ordinary shares at 279.75 pence to 280.25 pence and sold 685,425 shares at 280 pence to 280.5 pence. In the Gamma Communications filing, Investec, identified as joint broker to Gamma Communications, bought 82,076 ordinary shares at 961.67 to 966 and sold 82,076 shares at 960 to 966. Both filings said the trades were made by an exempt principal trader with recognised intermediary status acting in a client-serving capacity, with no cash-settled derivatives, stock-settled derivatives, options exercises or other dealings reported, and no indemnity, option or other relevant arrangements disclosed.

Terms & Concepts
  • Rule 8.5: A UK Takeover Code disclosure requirement covering dealings by an exempt principal trader with recognised intermediary status when acting in a client-serving capacity during an offer period.
  • Exempt principal trader: A dealing entity that can trade during a takeover offer period under specific Takeover Code rules, subject to public disclosure requirements.
  • Recognised intermediary status: A status under the UK Takeover Code that applies to certain market intermediaries and affects how their dealing disclosures are made.